Drug Trial News

RSS
New anti-HER2 drug shows promising anti-tumor activity in gullet, stomach and bowel cancers

New anti-HER2 drug shows promising anti-tumor activity in gullet, stomach and bowel cancers

Inexpensive and effective drug does not reduce major adverse cardiovascular event rates

Inexpensive and effective drug does not reduce major adverse cardiovascular event rates

New single-dose antibiotic effectively treats uncomplicated gonorrhea infections

New single-dose antibiotic effectively treats uncomplicated gonorrhea infections

Oral antibiotic shows promise to cure uncomplicated gonorrhea

Oral antibiotic shows promise to cure uncomplicated gonorrhea

AstraZeneca to present Phase III CVOT DECLARE-TIMI 58 results at AHA Scientific Sessions

AstraZeneca to present Phase III CVOT DECLARE-TIMI 58 results at AHA Scientific Sessions

Phase 2 study of ziresovir for treating hospitalized RSV infected infants achieves significant progress

Phase 2 study of ziresovir for treating hospitalized RSV infected infants achieves significant progress

Phase 2 STEMTRA trial using SB623 cells for treating traumatic brain injury meets primary endpoint

Phase 2 STEMTRA trial using SB623 cells for treating traumatic brain injury meets primary endpoint

Phase III CLL14 study evaluating Venclexta plus Gazyva to treat CLL meets its primary endpoint

Phase III CLL14 study evaluating Venclexta plus Gazyva to treat CLL meets its primary endpoint

New City of Hope CAR T cell trial focuses on HER2-positive breast cancer patients with brain metastases

New City of Hope CAR T cell trial focuses on HER2-positive breast cancer patients with brain metastases

Study highlights accuracy of DecisionDx-Melanoma prognostic test in patients with Stage II-IIIA melanoma

Study highlights accuracy of DecisionDx-Melanoma prognostic test in patients with Stage II-IIIA melanoma

AEGEA Medical begins PACE II clinical study in women who underwent endometrial ablation

AEGEA Medical begins PACE II clinical study in women who underwent endometrial ablation

Investigational drug targeting the opioid system may help reduce symptoms of major depression

Investigational drug targeting the opioid system may help reduce symptoms of major depression

Hormone injections reduce risk for early menopause from breast cancer chemotherapy

Hormone injections reduce risk for early menopause from breast cancer chemotherapy

Biogen and Eisai present detailed results from phase 1b study of aducanumab at CTAD meeting

Biogen and Eisai present detailed results from phase 1b study of aducanumab at CTAD meeting

Study reveals safety, efficacy of brexpiprazole for schizophrenia patients with severe psychotic symptoms

Study reveals safety, efficacy of brexpiprazole for schizophrenia patients with severe psychotic symptoms

High-impact clinical trial results could affect kidney-related medical care

High-impact clinical trial results could affect kidney-related medical care

The Lancet Infectious Diseases journal publishes clinical trial results for Shionogi’s cefiderocol

The Lancet Infectious Diseases journal publishes clinical trial results for Shionogi’s cefiderocol

Novel drug extends survival for women with HR-positive metastatic breast cancer

Novel drug extends survival for women with HR-positive metastatic breast cancer

HPTN 075 study shows high risk of HIV infection among MSM and TGW in sub-Saharan Africa

HPTN 075 study shows high risk of HIV infection among MSM and TGW in sub-Saharan Africa

Advanced breast cancer patients can benefit from immunotherapy-chemotherapy combination

Advanced breast cancer patients can benefit from immunotherapy-chemotherapy combination